
Please try another search
(Reuters) -Shares of New Zealand's Synlait Milk Ltd hit a record low on Monday after second-largest shareholder a2 Milk said it was cancelling an exclusive manufacturing and supply rights for some of its infant milk formula products.
A2 Milk, which owns 19.83% of Synlait, issued the cancellation notices earlier in the day, saying Synlait's delivery performance during fiscal 2023 was below the required level for it to maintain such rights.
The companies had signed the agreement more than seven years ago to increase production of some a2 Milk's infant formula products.
Synlait disputed a2's right to cancel the agreements, saying that the deal will hold until the matter was resolved per due process. Shares of Synlait fell as much as 7.0% to their record low level of NZ$1.190 as at 0321 GMT, while a2 Milk shares slipped 1.6%.
The dispute resolution process involves a 20-business day period of good faith talks between Synlait and A2 Milk followed by arbitration, said Synlait, while also reaffirming its fiscal 2023 guidance a week ahead of its full-year results announcement.
Removing Synlait's exclusivity will give a2 a chance to expand production of its English label product at any facility at a time when one of its largest markets, China, introduces stringent regulations for infant formula.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.